Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.8 - $7.24 $657 - $991
-137 Reduced 0.64%
21,349 $6,000
Q4 2021

Feb 11, 2022

SELL
$8.58 - $15.54 $19,202 - $34,778
-2,238 Reduced 9.43%
21,486 $10,000
Q2 2021

Aug 11, 2021

SELL
$17.92 - $27.8 $73,400 - $113,868
-4,096 Reduced 14.72%
23,724 $493,000
Q1 2021

May 13, 2021

SELL
$19.88 - $49.2 $38,090 - $94,267
-1,916 Reduced 6.44%
27,820 $673,000
Q1 2020

May 06, 2020

BUY
$9.94 - $54.8 $295,575 - $1.63 Million
29,736 New
29,736 $400,000

About Motus GI Holdings, Inc.


  • Ticker MOTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,996,840
  • Description
  • Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
More about MOTS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.